`
`Prior U.S. Cls.: 6, 18, 44, 46, 51, and 52
`United States Patent and Trademark Office Reg. No. 2,443,435
`
`Registered Apr. 10, 2001
`
`TRADEMARK
`PRINCIPAL REGISTER
`
`DEPOTREX
`
`(MASSACHUSETTS CORPORA-
`
`INC.
`
`BIOTEK,
`TION)
`21-C OLYMPIA AVENUE
`WOBURN,MA 0180!
`
`FOR: PHARMACEUTICAL PREPARATIONS,
`NAMELY, LONG-TERM DELIVERY SYSTEMS
`COMPRISED OF MICROCAPSULES OF NALTREX-
`ONE AND BIODEGRADABLE POLYMERS FOR
`
`THE TREATMENT OF DRUG ADDICTION, ALCO-
`HOLISM AND OTHER DISEASES, IN CLASS 5 (U.S.
`CLS.6, 18, 44, 46, 51 AND 52).
`
`FIRST USE 9-23-1999; IN COMMERCE 5-30-2000.
`
`SN 75-744,660, FILED 7-7-1999.
`
`VERNA BETH RIRIE, EXAMINING ATTORNEY
`
`APOTEX EXHIBIT 1057
`APOTEX EXHIBIT 1057
`Apotex v. Alkermes
`Apotex v. Alkermes
`IPR2025-00514
`IPR2025-00514
`
`